Chronic hepatitis B-related liver fibrosis
Clinical trials for Chronic hepatitis B-related liver fibrosis explained in plain language.
Never miss a new study
Get alerted when new Chronic hepatitis B-related liver fibrosis trials appear
Sign up with your email to follow new studies for Chronic hepatitis B-related liver fibrosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to tame liver scarring in hepatitis b
Disease control CompletedThis study tests a drug called hydronidone in 150 adults with liver scarring caused by chronic hepatitis B. Participants take the capsules three times daily for 28 days. The main goal is to check for side effects and ensure the drug is safe. This is an early-phase trial, so it fo…
Matched conditions: CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS
Phase 2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Healthy men help unravel how liver fibrosis drug leaves the body
Knowledge-focused CompletedThis study looks at how the drug Hydronidone is absorbed, broken down, and removed from the body. Eight healthy Chinese men will take a single dose with a radioactive tracer so researchers can measure the drug in blood, urine, and stool. The goal is to understand the drug's journ…
Matched conditions: CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS
Phase 1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Sep 22, 2026 00:00 UTC